FDA Refuses Antibiotic-Contaminated Shrimp from China and Vietnam in July

In July, the U.S. Food and Drug Administration (FDA) reported that 3 out of the 85 (3.5%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics. Through the first seven months of the year, the FDA has refused a total of 50 entry lines of shrimp for reasons related to veterinary drug residues, compared to […]

Filed Under


FDA Reports Historic Low in Seafood Entry Line Refusals in June

Yesterday, the U.S. Food and Drug Administration (FDA) reported refusing a total of just 55 seafood entry lines in June. This represents, by a significant margin, the lowest monthly total of seafood entry line refusals for any month going back to October 2001, the first month for which data are reported on the FDA’s website. Because the last seafood entry line refusal […]

Filed Under


Recently Published Academic Studies Highlight the Importance of Monitoring Antimicrobial-Resistant Pathogens in Imported Shrimp

When President Trump signed the Consolidated Appropriations Act 2019 into law last month, the bill provided the U.S. Food and Drug Administration (FDA) with “$500,000 to test Antibiotic Resistance in Imported Seafood.” By specifically funding a testing program, Congress emphasized the importance of detecting and monitoring antimicrobial pathogens on imported seafood, including shrimp.  Congress’s creation of a new testing program coincides […]

Filed Under


FDA Cracks Down on Indian Shrimp to Begin 2019

In 2017 and 2018, the U.S. Food and Drug Administration (FDA) refused a total of twenty-seven (27) entry lines of Indian shrimp for reasons related to banned antibiotics. For these two years, Indian shrimp accounted for one out of every five entry lines of shrimp refused for banned antibiotics (27 out of 108). Yet, shrimp sourced from India accounts for more […]

Filed Under


2018 Refusals of Antibiotic-Contaminated Shrimp in Line with 2017

For the month of December, the U.S. Food and Drug Administration (FDA) reports that 3 out of the 78 (3.8%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics. Additionally, the FDA updated its reporting for the month of November to include an additional three entry line refusals of shrimp for reasons related to banned antibiotics. […]

Filed Under


Even With More Rejections in November, 2018 Likely to Have Lowest Number of Refusals of Shrimp Imports for Banned Antibiotics in Over a Decade

For the month of November, the U.S. Food and Drug Administration (FDA) reports that 4 out of the 61 (6.6%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics. So far this year, there has been a total of 47 shrimp entry lines refused for reasons related to banned antibiotics. Absent a significant change in trends […]

Filed Under


European Commission Audit Report Reveals Reasons for Flood of Indian Shrimp into the United States

On November 8th, the European Commission’s Directorate General for Health and Food Safety made public the report of its audit and evaluation of the Indian government’s control of residues and contaminants in live animals and animal products including controls on veterinary medicinal products. The audit report shows the extensive, unique controls that the Indian government has installed to safeguard against exporting […]

Filed Under


Influx of Indian Shrimp in the U.S. Market Causes Health Concerns

India is the leading source of shrimp found by FDA to be contaminated with either salmonella or banned antibiotics In August 2013, the U.S. Department of Commerce issued a final determination finding that the Indian government provided significant countervailable subsidies to Indian shrimp producers and exporters.[1] Unfortunately, the U.S. government has taken no action to countervail those subsidies since Commerce […]

Filed Under


FDA Reports Refusals of Shrimp Imports Contaminated with Banned Antibiotics from a Wide Variety of Countries

For the month of October, the U.S. Food and Drug Administration (FDA) reports that 4 out of the 96 (4.2%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics. The FDA additionally updated its reporting for the month of September to now include an additional refusal of a shrimp entry line for reasons related to […]

Filed Under


Indian Shrimp Exporter Added to FDA Import Alert on Chloramphenicol

On Tuesday, the U.S. Food and Drug Administration (FDA) added Kader Exports Private Limited, of Andhra Pradesh, India, to Import Alert 16-127, “Detention without Physical Examination of Crustaceans Due to Chloramphenicol.” Kader Exports is the first Indian shrimp exporter to be included on this Import Alert. The FDA’s Import Alert on chloramphenicol explains that “[c]hloramphenicol is a broad-spectrum antibiotic that is […]

Filed Under